117th Congress · SENATE BILLENACTED

S. 164Advancing Education on Biosimilars Act of 2021

A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.

Health
Introduced Feb 2, 2021
Last action Apr 23, 2021
Pipeline · Bill → Law
Step 1
Introduced
Feb 2, 2021
Step 2
Referred
Feb 2, 2021
HELP
Step 3
Committee
Mar 3, 2021
Step 4
Senate
Mar 3, 2021
Passed Senate
Step 5
House floor
Moves to House
Step 6
Resolve Changes
Step 7
Signed
Apr 23, 2021
SummaryCRS Summary

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.

Provisions · 2 sectionsEnrolled
Similar Bills · 2 matches
BillText overlapStatus
H.R. 19Lower Costs, More Cures Act of 2021
1%
INCORPORATED
H.R. 1873Advancing Education on Biosimilars Act of 2021
100%
INCORPORATED
Roll Call Votes · 1
Timeline · 17 actions
Apr 23, 2021
Signed by President.
Apr 23, 2021
Became Public Law No: 117-8.
Apr 20, 2021
Presented to President.
Apr 14, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
Apr 14, 2021
Considered under suspension of the rules.
Apr 14, 2021
DEBATE - The House proceeded with forty minutes of debate on S. 164.
Apr 14, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 14, 2021
Considered as unfinished business.
Apr 14, 2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).ROLL CALLpass
Apr 14, 2021
Motion to reconsider laid on the table Agreed to without objection.
Mar 8, 2021
Message on Senate action sent to the House.
Mar 8, 2021
Received in the House.
Mar 8, 2021
Held at the desk.
Mar 3, 2021
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Mar 3, 2021
Passed Senate without amendment by Unanimous Consent.
Feb 2, 2021
Introduced in Senate
Feb 2, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.